PUBLISHER: Value Market Research | PRODUCT CODE: 1402156
PUBLISHER: Value Market Research | PRODUCT CODE: 1402156
Global Ocular Drug Delivery Technology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
The global demand for Ocular Drug Delivery Technology Market is presumed to reach the market size of nearly USD 42.85 BN by 2030 from USD 18.21 BN in 2022 with a CAGR of 11.29% under the study period 2023 - 2030.
Ocular drug delivery technology refers to specialized techniques and systems designed to administer medications to the eye. These technologies aim to effectively deliver therapeutic agents, such as drugs or treatments, to specific ocular tissues and structures for the treatment of various eye conditions and diseases.
MARKET DYNAMICS
The ocular drug delivery technology market is experiencing growth due to several driving factors. Primarily, the increasing prevalence of eye diseases, including glaucoma, macular degeneration, and diabetic retinopathy, fuels the demand for advanced drug delivery systems tailored for ocular treatments. Technological innovations play a significant role, with ongoing advancements in nanotechnology, implants, sustained-release formulations, and targeted delivery systems enhancing drug efficacy and precision in ocular treatments. These innovations attract investments and drive market expansion. The targeted and controlled drug delivery demand for specific eye tissues also propels market growth, offering more effective treatment options while minimizing systemic side effects. Additionally, the aging population's susceptibility to eye disorders contributes to increased demand for ocular drug delivery systems. Rising research and development investments, patient preference for non-invasive treatments, and supportive government policies promoting innovative healthcare technologies further stimulate the market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of ocular drug delivery technology. The growth and trends of ocular drug delivery technology industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the ocular drug delivery technology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Technology
- Topical
- Iontophoresis
- Ocular Insert
- Intraocular Implants
- In Situ Gel & Punctal Plugs
- Others
By Disease Type
- Glaucoma
- Diabetic Retinopathy
- Dry Eye Syndrome
- Macular Degeneration
- Cataract
- Diabetic Macular Edema
- Others
By End Users
- Hospitals
- Ophthalmic Clinics
- Ambulatory Surgical Centers
- Homecare Settings
REGIONAL ANALYSIS
This section covers the regional outlook, which accentuates current and future demand for the Ocular Drug Delivery Technology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Ocular Drug Delivery Technology market include Allergan Plc., Bausch Health Company (Valeant Pharmaceuticals International)., Santen Pharmaceutical Co. Ltd., Alimera Sciences Inc., Ocular Therapeutix Inc., Envisia Therapeutics Inc., EyeGate Pharma Inc., Novartis AG., Johnson & Johnson Vision Care Inc., and Pfizer Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . OCULAR DRUG DELIVERY TECHNOLOGY - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Technology
- 3.7.2 Market Attractiveness Analysis By Disease Type
- 3.7.3 Market Attractiveness Analysis By End Users
- 3.7.4 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . GLOBAL OCULAR DRUG DELIVERY TECHNOLOGY MARKET ANALYSIS BY TECHNOLOGY
- 5.1 Overview by Technology
- 5.2 Historical and Forecast Data
- 5.3 Analysis by Technology
- 5.4 Topical Historic and Forecast Sales by Regions
- 5.5 Iontophoresis Historic and Forecast Sales by Regions
- 5.6 Ocular Insert Historic and Forecast Sales by Regions
- 5.7 Intraocular Implants Historic and Forecast Sales by Regions
- 5.8 In Situ Gel & Punctal Plugs Historic and Forecast Sales by Regions
- 5.9 Others Historic and Forecast Sales by Regions
6 . GLOBAL OCULAR DRUG DELIVERY TECHNOLOGY MARKET ANALYSIS BY DISEASE TYPE
- 6.1 Overview by Disease Type
- 6.2 Historical and Forecast Data
- 6.3 Analysis by Disease Type
- 6.4 Glaucoma Historic and Forecast Sales by Regions
- 6.5 Diabetic Retinopathy Historic and Forecast Sales by Regions
- 6.6 Dry Eye Syndrome Historic and Forecast Sales by Regions
- 6.7 Macular Degeneration Historic and Forecast Sales by Regions
- 6.8 Cataract Historic and Forecast Sales by Regions
- 6.9 Diabetic Macular Edema Historic and Forecast Sales by Regions
- 6.10. Others Historic and Forecast Sales by Regions
7 . GLOBAL OCULAR DRUG DELIVERY TECHNOLOGY MARKET ANALYSIS BY END USERS
- 7.1 Overview by End Users
- 7.2 Historical and Forecast Data
- 7.3 Analysis by End Users
- 7.4 Hospitals Historic and Forecast Sales by Regions
- 7.5 Ophthalmic Clinics Historic and Forecast Sales by Regions
- 7.6 Ambulatory Surgical Centers Historic and Forecast Sales by Regions
- 7.7 Homecare Settings Historic and Forecast Sales by Regions
8 . GLOBAL OCULAR DRUG DELIVERY TECHNOLOGY MARKET ANALYSIS BY GEOGRAPHY
- 8.1. Regional Outlook
- 8.2. Introduction
- 8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
- 8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
- 8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
- 8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
- 8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis
9 . COMPETITIVE LANDSCAPE OF THE OCULAR DRUG DELIVERY TECHNOLOGY COMPANIES
- 9.1. Ocular Drug Delivery Technology Market Competition
- 9.2. Partnership/Collaboration/Agreement
- 9.3. Merger And Acquisitions
- 9.4. New Product Launch
- 9.5. Other Developments
10 . COMPANY PROFILES OF OCULAR DRUG DELIVERY TECHNOLOGY INDUSTRY
- 10.1. Company Share Analysis
- 10.2. Market Concentration Rate
- 10.3. Allergan Plc.
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
- 10.4. Bausch Health Company (Valeant Pharmaceuticals International).
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
- 10.5. Santen Pharmaceutical Co. Ltd.
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
- 10.6. Alimera Sciences Inc.
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
- 10.7. Ocular Therapeutix Inc.
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
- 10.8. Envisia Therapeutics Inc.
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
- 10.9. EyeGate Pharma Inc.
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
- 10.10. Novartis AG.
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
- 10.11. Johnson & Johnson Vision Care Inc.
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
- 10.12. Pfizer Inc.
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- Analysis by Technology (USD MN)
- Topical Market Sales by Geography (USD MN)
- Iontophoresis Market Sales by Geography (USD MN)
- Ocular Insert Market Sales by Geography (USD MN)
- Intraocular Implants Market Sales by Geography (USD MN)
- In Situ Gel & Punctal Plugs Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Analysis Market by Disease Type (USD MN)
- Glaucoma Market Sales by Geography (USD MN)
- Diabetic Retinopathy Market Sales by Geography (USD MN)
- Dry Eye Syndrome Market Sales by Geography (USD MN)
- Macular Degeneration Market Sales by Geography (USD MN)
- Cataract Market Sales by Geography (USD MN)
- Diabetic Macular Edema Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Analysis by End Users (USD MN)
- Hospitals Market Sales by Geography (USD MN)
- Ophthalmic Clinics Market Sales by Geography (USD MN)
- Ambulatory Surgical Centers Market Sales by Geography (USD MN)
- Homecare Settings Market Sales by Geography (USD MN)
- Global Ocular Drug Delivery Technology Market Sales by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- South East Asia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Ocular Drug Delivery Technology Report
- Market Research Process
- Market Research Methodology
- Global Ocular Drug Delivery Technology Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Technology
- Market Attractiveness Analysis by Disease Type
- Market Attractiveness Analysis by End Users
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Technology (USD MN)
- Topical Market Sales by Geography (USD MN)
- Iontophoresis Market Sales by Geography (USD MN)
- Ocular Insert Market Sales by Geography (USD MN)
- Intraocular Implants Market Sales by Geography (USD MN)
- In Situ Gel & Punctal Plugs Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Market Analysis by Disease Type (USD MN)
- Glaucoma Market Sales by Geography (USD MN)
- Diabetic Retinopathy Market Sales by Geography (USD MN)
- Dry Eye Syndrome Market Sales by Geography (USD MN)
- Macular Degeneration Market Sales by Geography (USD MN)
- Cataract Market Sales by Geography (USD MN)
- Diabetic Macular Edema Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Market Analysis by End Users (USD MN)
- Hospitals Market Sales by Geography (USD MN)
- Ophthalmic Clinics Market Sales by Geography (USD MN)
- Ambulatory Surgical Centers Market Sales by Geography (USD MN)
- Homecare Settings Market Sales by Geography (USD MN)
- Global Market Sales (USD MN)
- North America Market Sales (USD MN)
- Europe Market Sales (USD MN)
- Asia Pacific Market Sales (USD MN)
- Latin America Market Sales (USD MN)
- Middle East & Africa Market Sales (USD MN)
- Recent Development in Industry
- Top Company Market Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
